Skip to main content
logo
Daré Bioscience logo
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7290
-0.0187 (-2.50%)
At close: Oct 14, 2026, 4:00 PM EDT
0.7100
-0.0190 (-2.61%)
Pre-market: Oct 15, 2026, 6:36 AM EDT

Daré Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-10.99-13.4-4.05-30.16-30.95-38.7
Depreciation & Amortization
2.131.630.040.040.020.03
Loss (Gain) From Sale of Assets
--0.6---
Stock-Based Compensation
1.51.52.22.532.161.6
Other Operating Activities
0.770.590.79-0.84-0.02-0.42
Change in Accounts Receivable
-0.01-0.01-0.75-0.56-0.69
Change in Accounts Payable
-0.54-0.26-1.931.36-0.081.08
Change in Unearned Revenue
1.632.092.82-4.577.768.98
Change in Other Net Operating Assets
-5.79-2.035-7.973.57-0.65
Operating Cash Flow
-11.29-9.895.47-38.86-18.09-28.76
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.46-0.39-0.57-0.63-0.06-0.01
Investing Cash Flow
-0.46-0.39-0.57-0.63-0.06-0.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-0.490.560.6--
Total Debt Issued
0.490.490.560.6--
Long-Term Debt Repaid
--1.82-0.58-0.33--
Net Debt Issued (Repaid)
-2.15-1.33-0.020.27--
Issuance of Common Stock
20.2820.930.4510.651.3475.85
Other Financing Activities
-0.35-0.32-0.084.72--
Financing Cash Flow
19.3119.280.3515.641.3475.85

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.030.01-0.07-0.01-0.2-0.06
Net Cash Flow
7.589.015.19-23.86-1747

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.76-10.274.9-39.49-18.15-28.78
Free Cash Flow Growth
------
Free Cash Flow Margin
-860.62%-997.01%50086.97%-1406.26%-181.52%-
Free Cash Flow Per Share
-0.83-0.920.58-5.43-2.58-5.65
Levered Free Cash Flow
-6.91-4.81-7.62-27.18-6.8-15.28
Unlevered Free Cash Flow
-6.91-4.81-7.62-27.18-6.8-15.28

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-4.71-0.215.89-10.4310.78.73
SEC Filings: 10-K · 10-Q